Skip to main content
    S

    Shattuck Labs Inc (STTK)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.66
    +0.01 (+0.22%)

    Market Cap: $473.57M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Shattuck Labs Inc (STTK) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Shattuck Labs are Tectonic Therapeutic (TECX), SAB Biotherapeutics (SABS) and Syndax Pharmaceuticals (SNDX). By market cap, Shattuck Labs ranks 5th of the 13 companies on this page; Syndax Pharmaceuticals (SNDX) is the largest at $850.77M.

    Peer Comparison

    STTK's revenue growth of -66.6% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Shattuck Labs (STTK)$473.57MN/AN/A0.0%N/A-66.6%0.00%
    Tectonic Therapeutic, Inc. (TECX)$413.27MN/AN/A0.0%N/A0.0%0.00%
    SAB Biotherapeutics Inc (SABS)$266.66MN/AN/A0.0%N/A-62.4%0.00%
    Syndax Pharmaceuticals Inc (SNDX)$850.77MN/A2.8x-72.3%-65.0%81.6%0.00%
    DiaMedica Therapeutics Inc (DMAC)$474.29MN/AN/A0.0%N/A0.0%0.00%
    Galectin Therapeutics Inc (GALT)$307.59MN/AN/A0.0%671.1%0.0%0.00%
    X4 Pharmaceuticals Inc (XFOR)$318.59MN/A21.7x0.0%-36.9%63.1%0.00%
    CytomX Therapeutics Inc (CTMX)$444.73MN/A31.0x0.0%-32.8%-71.7%0.00%
    Puma Biotechnology Inc (PBYI)$401.70M15.0x1.6x10.3%N/A1.1%0.00%
    Indaptus Therapeutics Inc (INDP)$422.38MN/AN/A0.0%N/A0.0%0.00%
    Immix Biopharma Inc (IMMX)$657.09MN/AN/A0.0%-14.9%0.0%0.00%
    Avalo Therapeutics Inc (AVTX)$448.71MN/AN/A0.0%N/A-69.3%0.00%
    Climb Bio Inc (CLYM)$608.53MN/AN/A0.0%N/A0.0%0.00%
    Peer median$433.55M15.0x12.2x0.0%-32.8%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Shattuck Labs, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Tectonic Therapeutic, Inc. (TECX)
    Tectonic Therapeutic, Inc. engages in the discovery of antibodies and other biologic drugs targeting G-protein-coupled receptors (GPCRs) to develop novel...
    TECX competitors
    SAB Biotherapeutics Inc (SABS)
    SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology.
    SABS competitors
    Syndax Pharmaceuticals Inc (SNDX)
    Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer.
    SNDX competitors
    DiaMedica Therapeutics Inc (DMAC)
    DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company, develops treatments for neurological and kidney diseases.
    DMAC competitors
    Galectin Therapeutics Inc (GALT)
    Galectin Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the research and development of therapies for fibrotic...
    GALT competitors
    X4 Pharmaceuticals Inc (XFOR)
    X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development...
    XFOR competitors
    CytomX Therapeutics Inc (CTMX)
    CytomX Therapeutics, Inc. is an oncology-focused biopharmaceutical company in the United States.
    CTMX competitors
    Puma Biotechnology Inc (PBYI)
    Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States...
    PBYI competitors
    Indaptus Therapeutics Inc (INDP)
    Indaptus Therapeutics Inc. is a pioneering biotechnology firm focused on advancing immunotherapies that aim to transform cancer treatment paradigms.
    INDP competitors
    Immix Biopharma Inc (IMMX)
    Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology...
    IMMX competitors
    Avalo Therapeutics Inc (AVTX)
    Avalo Therapeutics Inc is a forward-thinking clinical-stage biotechnology company focused on developing transformative therapies for rare and underserved...
    AVTX competitors
    Climb Bio Inc (CLYM)
    Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases.
    CLYM competitors

    Frequently Asked Questions About STTK

    Who are Shattuck Labs' main competitors?

    The companies most similar to Shattuck Labs include Tectonic Therapeutic (TECX), SAB Biotherapeutics (SABS), Syndax Pharmaceuticals (SNDX), DiaMedica Therapeutics (DMAC) and Galectin Therapeutics (GALT), listed from the closest match.

    Who is Shattuck Labs' biggest competitor?

    Syndax Pharmaceuticals (SNDX) is the largest of the similar companies at $850.77M; Tectonic Therapeutic (TECX) is the closest match by business profile, size, sector and industry.

    How does STTK stock compare with its competitors?

    STTK's net margin is 0.0% against a peer median of 0.0%.

    Which of Shattuck Labs' competitors pays a higher dividend?

    Shattuck Labs pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Shattuck Labs bigger than its competitors?

    No. Shattuck Labs is 5th by market cap among the 13 companies on this page; the largest is Syndax Pharmaceuticals (SNDX) at $850.77M.